Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Neoplasms 1 HIV Infections 1

Interventions

Doxorubicin 18 Vincristine 15 Zidovudine 11 Bleomycin 11 Cyclophosphamide 9 Etoposide 8 Interferon alpha-2 6 Prednisone 5 Cytarabine 5 tecogalan 4 sargramostim 4 Rituximab 4 Polymerase Chain Reaction 4 Liposomes 4 Filgrastim 4 Dexamethasone 4 Methotrexate 3 Leucovorin 3 Fluorouracil 3 interferon alfa-n1 2 Watchful Waiting 2 Vinblastine 2 Tumor Necrosis Factor-alpha 2 Thalidomide 2 Semaxinib 2 Ritonavir 2 Peripheral Blood Stem Cell Transplantation 2 Mitoxantrone 2 Light Coagulation 2 Isotretinoin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × HIV Infections × Nurse Clinicians × Clear all

NCT00466258 2009-11-25

LINFOTARGAM

PETHEMA Foundation

Phase 4 Completed

HIV Infections, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡